Antiepileptic drug treatment in children

Stavros M Hadjiloizou1, Blaise F D Bourgeois

  • 1Harvard Medical School, Division of Epilepsy & Clinical Neurophysiology, Department of Neurology, Children's Hospital Boston, Boston, MA 02115, USA. stavros.hadjiloizou@childrens.harvard.edu

Insights

Pediatric epilepsy treatment focuses on improving quality of life by minimizing side effects of antiepileptic drugs. This review details commonly used antiepileptic drugs for childhood epilepsy syndromes and seizures.

Area of Science:

  • Pediatric Neurology
  • Pharmacology

Background:

  • Epilepsy is a common childhood neurological disorder, with antiepileptic drugs (AEDs) as a primary treatment.
  • Current treatment goals emphasize enhancing quality of life by controlling seizures and reducing medication side effects.

Purpose of the Study:

  • To review the principles of pediatric epilepsy treatment.
  • To summarize the profiles of commonly used AEDs in children.
  • To provide a treatment paradigm for specific childhood epilepsy syndromes and seizures.

Main Methods:

  • Literature review of recent advances in AED development and pediatric epilepsy treatment.
  • Analysis of essential properties, indications, and interactions of AEDs.
  • Consideration of age as a factor in epilepsy phenotype and treatment.

Main Results:

  • Significant advances in AED development over the last 15 years aim to improve treatment efficacy and tolerability.
  • Understanding AED properties, indications, and interactions is crucial for optimizing treatment outcomes.
  • Age-specific considerations are vital for effective pediatric epilepsy management.

Conclusions:

  • Optimizing pediatric epilepsy treatment requires a comprehensive understanding of AEDs and individualized approaches.
  • The review provides a framework for selecting appropriate AEDs based on seizure type, epilepsy syndrome, and patient age.
  • Future treatment strategies should continue to prioritize seizure control alongside minimized adverse effects to enhance children's quality of life.

Related Concept Videos

Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...